NPI: 1497050470 · EASTON, PA 18045 · Infusion Therapy Clinic/Center · NPI assigned 01/21/2011
Authorized official WOLFE, SCOTT controls 20+ related entities in our dataset. Read more
| Authorized Official | WOLFE, SCOTT (SENIOR VP FINANCE/CFO) |
| NPI Enumeration Date | 01/21/2011 |
Other providers sharing the same authorized official: WOLFE, SCOTT
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 201 | $37K |
| 2019 | 2,382 | $208K |
| 2020 | 22,311 | $966K |
| 2021 | 90,153 | $3.44M |
| 2022 | 30,166 | $1.40M |
| 2023 | 34,789 | $1.54M |
| 2024 | 23,522 | $878K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 14,920 | 14,421 | $1.93M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 11,495 | 10,973 | $1.71M |
| G0378 | Hospital observation service, per hour | 841 | 746 | $755K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7,296 | 6,935 | $588K |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3,315 | 3,124 | $544K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2,272 | 2,240 | $237K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1,206 | 1,167 | $204K |
| T1015 | Clinic visit/encounter, all-inclusive | 4,400 | 1,558 | $164K |
| X0620 | 781 | 736 | $159K | |
| 80053 | Comprehensive metabolic panel | 15,214 | 14,077 | $147K |
| 99050 | 1,471 | 1,331 | $146K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,797 | 1,715 | $136K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1,167 | 1,166 | $129K |
| 80050 | General health panel | 2,125 | 2,057 | $90K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 16,890 | 15,679 | $84K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1,679 | 1,637 | $56K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 6,307 | 5,936 | $50K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 946 | 916 | $46K |
| 80061 | Lipid panel | 3,299 | 3,232 | $44K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 502 | 494 | $43K |
| X0616 | 231 | 231 | $42K | |
| 70450 | Computed tomography, head or brain; without contrast material | 678 | 649 | $39K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,107 | 1,086 | $37K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 475 | 321 | $36K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 471 | 463 | $34K |
| X0621 | 150 | 121 | $34K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 592 | 562 | $31K |
| 84443 | Thyroid stimulating hormone (TSH) | 1,499 | 1,456 | $30K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 148 | 146 | $27K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 770 | 436 | $26K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 108 | 107 | $24K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 586 | 548 | $23K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 871 | 858 | $23K |
| 87631 | 164 | 162 | $22K | |
| 86003 | 152 | 148 | $22K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 383 | 322 | $22K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 434 | 388 | $21K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 278 | 270 | $21K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 475 | 462 | $20K |
| 86803 | 938 | 927 | $17K | |
| 71045 | Radiologic examination, chest; single view | 2,924 | 2,783 | $17K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 70 | 63 | $16K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 128 | 127 | $16K |
| 80081 | 190 | 185 | $15K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 93 | 91 | $15K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 410 | 398 | $14K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 649 | 618 | $14K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1,787 | 1,676 | $14K |
| 93971 | 235 | 231 | $14K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 645 | 614 | $14K |
| J1756 | Injection, iron sucrose, 1 mg | 2,181 | 1,105 | $13K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 71 | 69 | $12K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,812 | 1,772 | $12K |
| 86480 | 167 | 162 | $11K | |
| 83690 | 2,676 | 2,527 | $11K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,632 | 1,539 | $11K |
| 74183 | 28 | 28 | $11K | |
| 97162 | 164 | 162 | $11K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 498 | 490 | $11K |
| 81001 | 3,913 | 3,682 | $10K | |
| 71046 | Radiologic examination, chest; 2 views | 768 | 737 | $10K |
| 97161 | 148 | 147 | $10K | |
| 76770 | 232 | 226 | $10K | |
| S9083 | Global fee urgent care centers | 88 | 82 | $9K |
| 71250 | 161 | 157 | $9K | |
| 82728 | 799 | 775 | $9K | |
| 84702 | 556 | 447 | $9K | |
| 83970 | 222 | 217 | $8K | |
| 73610 | 484 | 471 | $8K | |
| 83880 | 260 | 248 | $7K | |
| 76536 | 145 | 145 | $7K | |
| 85027 | 1,144 | 1,029 | $7K | |
| 86618 | 312 | 310 | $7K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,098 | 1,076 | $7K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 110 | 109 | $7K |
| 86235 | 169 | 160 | $6K | |
| 84153 | 292 | 281 | $6K | |
| 84484 | 940 | 864 | $6K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 25 | 25 | $6K |
| 84439 | 839 | 819 | $6K | |
| 82607 | 534 | 523 | $6K | |
| 73562 | 460 | 356 | $6K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 102 | 102 | $6K |
| 82784 | 323 | 316 | $6K | |
| 82570 | 857 | 818 | $6K | |
| 93017 | 166 | 159 | $5K | |
| 83540 | 684 | 664 | $5K | |
| 96367 | 235 | 146 | $5K | |
| 87070 | 721 | 708 | $5K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 394 | 281 | $5K |
| 83735 | 781 | 691 | $5K | |
| 87340 | 342 | 340 | $5K | |
| 85610 | 1,362 | 1,215 | $5K | |
| 85379 | 470 | 461 | $4K | |
| 86038 | 294 | 290 | $4K | |
| 87040 | 273 | 252 | $4K | |
| 86255 | 241 | 236 | $4K | |
| 73630 | 416 | 365 | $4K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 74 | 72 | $4K |
| 73030 | 311 | 283 | $4K | |
| 85730 | 722 | 688 | $4K | |
| 73130 | 367 | 290 | $4K | |
| 82043 | 475 | 460 | $3K | |
| 81003 | 1,255 | 1,194 | $3K | |
| 73502 | 190 | 180 | $3K | |
| 73564 | 191 | 170 | $3K | |
| 83550 | 639 | 621 | $3K | |
| 76801 | 84 | 81 | $3K | |
| 87536 | 24 | 24 | $3K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 73 | 61 | $3K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 27 | 27 | $3K |
| 96417 | 71 | 51 | $3K | |
| 82550 | 440 | 415 | $3K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 191 | 191 | $3K |
| 72100 | 151 | 146 | $3K | |
| 73221 | 12 | 12 | $3K | |
| J3490 | Unclassified drugs | 1,121 | 713 | $3K |
| 82785 | 149 | 146 | $3K | |
| 73110 | 260 | 227 | $2K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 46 | 44 | $2K |
| 83605 | 371 | 350 | $2K | |
| 82105 | 121 | 119 | $2K | |
| 72110 | 115 | 114 | $2K | |
| 86592 | 564 | 559 | $2K | |
| 87186 | 294 | 284 | $2K | |
| 86850 | 296 | 282 | $2K | |
| 86140 | 738 | 704 | $2K | |
| 84703 | 232 | 219 | $2K | |
| 84403 | 73 | 71 | $2K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 220 | 213 | $2K |
| 93970 | 26 | 24 | $2K | |
| 87077 | 292 | 282 | $2K | |
| 36415 | Collection of venous blood by venipuncture | 3,148 | 2,482 | $2K |
| 86200 | 138 | 135 | $2K | |
| 82746 | 172 | 168 | $2K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 97 | 82 | $2K |
| 85652 | 617 | 596 | $2K | |
| 82950 | 250 | 246 | $2K | |
| 94729 | 61 | 61 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 197 | 158 | $2K |
| 86430 | 233 | 227 | $2K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,311 | 1,228 | $2K |
| 80076 | 178 | 169 | $1K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 923 | 761 | $1K |
| 76813 | 26 | 25 | $1K | |
| 84156 | 358 | 338 | $1K | |
| 85007 | 379 | 297 | $1K | |
| 83721 | 149 | 146 | $1K | |
| 86901 | 338 | 323 | $1K | |
| 84100 | 218 | 203 | $1K | |
| 86900 | 338 | 323 | $1K | |
| 74018 | 113 | 110 | $1K | |
| 86800 | 66 | 66 | $1K | |
| 86704 | 79 | 79 | $1K | |
| 84550 | 186 | 177 | $1K | |
| OP250 | 1,732 | 1,152 | $1K | |
| 82247 | 139 | 99 | $1K | |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | 12 | 12 | $987.88 |
| 300 | Patient transfer system <300 | 64 | 12 | $924.36 |
| 94726 | 38 | 38 | $923.22 | |
| 86706 | 69 | 69 | $905.97 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 314 | 296 | $860.84 |
| 97165 | 12 | 12 | $806.88 | |
| J2704 | Injection, propofol, 10 mg | 4,114 | 2,470 | $797.34 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 6,196 | 4,997 | $747.24 |
| 82803 | 44 | 44 | $723.63 | |
| 86705 | 43 | 43 | $675.68 | |
| 84165 | 53 | 53 | $650.21 | |
| 84481 | 32 | 28 | $614.33 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 3,414 | 2,698 | $601.27 |
| 77334 | 14 | 12 | $594.00 | |
| 82948 | 406 | 353 | $574.33 | |
| 76870 | 14 | 12 | $570.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 281 | 270 | $555.71 |
| 93880 | 13 | 13 | $520.22 | |
| 73600 | 51 | 50 | $503.00 | |
| 83001 | 26 | 26 | $478.80 | |
| 90715 | 25 | 25 | $478.61 | |
| 86376 | 62 | 62 | $443.25 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 796 | 701 | $441.41 |
| 87522 | Neg quan hep c or qual rna | 16 | 12 | $417.92 |
| J7050 | Infusion, normal saline solution, 250 cc | 805 | 297 | $416.24 |
| 93226 | 15 | 15 | $397.70 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 1,271 | 962 | $386.04 |
| 73140 | 39 | 36 | $374.93 | |
| 82805 | 12 | 12 | $373.05 | |
| 86160 | 14 | 14 | $371.62 | |
| 84146 | 14 | 13 | $345.60 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 5,660 | 4,828 | $327.65 |
| 73080 | 32 | 28 | $306.50 | |
| 84402 | 13 | 13 | $302.40 | |
| 93225 | 28 | 27 | $302.09 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 385 | 338 | $241.23 |
| 86762 | 13 | 13 | $231.76 | |
| 86787 | 12 | 12 | $224.04 | |
| 72050 | 13 | 12 | $219.68 | |
| 81025 | 196 | 178 | $218.76 | |
| 83002 | 12 | 12 | $216.92 | |
| 94060 | 24 | 24 | $207.31 | |
| 84145 | 13 | 13 | $204.33 | |
| 82553 | 26 | 26 | $202.41 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 1,738 | 1,451 | $202.33 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 1,103 | 905 | $195.43 |
| 73590 | 14 | 14 | $188.10 | |
| 81002 | 49 | 49 | $178.31 | |
| 86225 | 12 | 12 | $147.61 | |
| 83525 | 12 | 12 | $140.80 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 1,139 | 1,055 | $139.20 |
| 84132 | 34 | 34 | $135.54 | |
| 73560 | 14 | 12 | $133.98 | |
| 76830 | Ultrasound, transvaginal | 16 | 15 | $126.56 |
| 84295 | 32 | 32 | $125.94 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 17 | 14 | $95.18 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 75 | 52 | $91.00 |
| 85014 | 51 | 51 | $86.08 | |
| 82947 | 37 | 37 | $76.88 | |
| 87430 | 12 | 12 | $75.60 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 2,118 | 1,784 | $65.29 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 261 | 255 | $51.14 |
| 82077 | 48 | 43 | $42.12 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 1,169 | 954 | $39.72 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 1,365 | 1,246 | $4.60 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 144 | 126 | $0.05 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 97 | 87 | $0.00 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 237 | 160 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 73 | 63 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 15 | 13 | $0.00 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 31 | 29 | $0.00 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 13 | 12 | $0.00 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 17 | 13 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 780 | 677 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 101 | 77 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 39 | 30 | $0.00 |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | 33 | 33 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 61 | 59 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 18 | 15 | $0.00 |
| 80143 | 15 | 14 | $0.00 | |
| 80179 | 14 | 13 | $0.00 |